CNB
ADVM

City National Bank’s Adverum Biotechnologies ADVM Stock Holding History

City National Bank’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$88K Sell
1,065
-4,066
-79% -$519K ﹤0.01% 809
2015
Q2 		$834K Buy
+5,131
New +$1.73M 0.01% 519

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

City National Bank's ADVM Position: Q3 2015 in Review

City National Bank reduced its Adverum Biotechnologies (ADVM) stake by 79% in Q3 2015, selling an estimated $519K and leaving 1,065 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #809.

City National Bank first reported a position in ADVM in Q2 2015 and has held it in 2 quarters since. The position peaked at $834K in Q2 2015. 92 funds tracked by Wall St. Rank hold ADVM as of Q3 2015.

  • City National Bank held 1,065 shares of Adverum Biotechnologies worth $88K as of Q3 2015.
  • City National Bank sold 4,066 Adverum Biotechnologies shares in Q3 2015, an estimated $519K.
  • Adverum Biotechnologies made up ﹤0.01% of City National Bank's portfolio in Q3 2015, its #809 holding.
  • City National Bank first reported a position in Adverum Biotechnologies in Q2 2015 and has held it in 2 quarters since.
  • City National Bank's Adverum Biotechnologies position peaked at $834K in Q2 2015.
  • 92 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.